Interleukin-6 and Tumor Growth Factor-β are Risk Factors for Idiopathic Epistaxis

Lab Med. 2018 Oct 11;49(4):329-341. doi: 10.1093/labmed/lmy017.

Abstract

Objective: To evaluate the serum levels of interleukin (IL)-6, IL-8, tumor necrosis factor (TNF)-α, tumor growth factor (TGF)-β, endothelin, and immunoglobulin (Ig)E in patients with idiopathic epistaxis, compared with healthy control individuals.

Methods: Serum levels of IL-6, IL-8, TNF-α, TGF-β, endothelin, and IgE were evaluated in 110 patients with idiopathic epistaxis and 100 healthy controls using the enzyme-linked immunosorbent assay (ELISA) technique.

Results: Serum levels of IL-6 (P <.001) and TGF-β (P = .001) were significantly increased in patients with idiopathic epistaxis, compared with controls. TNF-α serum levels were significantly increased in male patients, compared with female patients (P = .053). We observed decreased antihistamine levels and increased expression of TGF-β (P = .02) and TNF-α (P = .02), respectively.

Conclusions: IL-6 and TGF-β appear to participate in the pathogenesis of idiopathic epistaxis. TNF-α may be considered a risk factor for male patients in developing epistaxis. Antihistamines may inhibit angiogenesis by decreasing expression of TGF-β and increasing expression of TNF-α.

MeSH terms

  • Adult
  • Cross-Sectional Studies
  • Cytokines / blood
  • Epistaxis / blood*
  • Epistaxis / epidemiology*
  • Female
  • Humans
  • Hypersensitivity
  • Interleukin-6 / blood*
  • Male
  • Risk Factors

Substances

  • Cytokines
  • Interleukin-6